ALUR

Allurion Technologies, Inc. · NYSE

Sector Health Technology
Industry Medical Specialties
Website allurion.com
Employees(FY) 268
ISIN US02008G1022

Performance

+0.78%

-15.04%

-44.76%

-67.17%

-90.7%

YTD

-89.64%

Profile

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.

Advanced Technical Analysis

Technical Analysis of ALUR 2024-12-20

The stock indicators reflect a mixed sentiment, with the Moving Average Score at 30 indicating a bearish outlook, while the Oscillators Score at 60 suggests bullish momentum. Overall, the Technical Score of 45 reinforces a neutral stance, highlighting uncertainty in the market direction.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of ALUR

Stock Rank

Recent News & Updates

2024-12-19 02:57
FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next(Yahoo Finance)
2024-12-01 19:00
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance(Businesswire)
2024-11-25 01:51
Allurion launches compounded GLP-1 program as FDA aims to ends access(Yahoo Finance)
2024-11-25 01:51
Allurion launches compounded GLP-1 program as FDA aims to end access(Yahoo Finance)
2024-11-24 19:00
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program(Businesswire)
2024-11-12 19:00
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update(Businesswire)
2024-11-03 19:10
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Societys Annual Conference(Businesswire)
2024-10-29 20:30
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024(Businesswire)
2024-10-22 20:00
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon(Businesswire)
2024-10-08 20:00
Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss(Businesswire)
2024-09-30 20:04
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss(Businesswire)
2024-09-05 05:30
Allurion Receives Continued Listing Standards Notice from NYSE(Businesswire)
2024-09-04 20:00
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity(Businesswire)
2024-09-02 20:00
Allurion Announces the Appointment of Eli Lilly Veteran, Keith Johns, to Its Board of Directors(Businesswire)
2024-08-27 20:28
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program(Businesswire)
2024-08-19 20:00
Allurion Announces the Appointment of Adrian Wild as Senior Vice President, International Commercial(Businesswire)
2024-08-15 04:05
Allurion Receives Continued Listing Standards Notice from NYSE(Businesswire)
2024-08-12 20:00
Allurion Reports Second Quarter 2024 Financial Results and Provides Business Update(Businesswire)
2024-07-16 04:05
Allurion to Report Second Quarter 2024 Financial Results on August 13, 2024(Businesswire)
2024-06-27 21:06
Allurion Announces Pricing of $20 million Public Offering and Concurrent Private Placement(Businesswire)
2024-06-25 20:36
Allurion Announces Launch of Offering of Common Stock and Warrants(Businesswire)
2024-06-20 03:49
Why Is Allurion (ALUR) Stock Up 140% Today?(Investorplace)
2024-06-19 20:00
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss(Businesswire)
2024-06-14 01:44
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy(Zacks)
2024-06-10 22:50
Sidoti Events, LLC's Virtual June Small-Cap Conference(Accesswire)
2024-06-10 21:35
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner(Zacks)
2024-06-10 20:00
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery(Businesswire)
2024-06-04 20:00
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer(Businesswire)
2024-05-29 20:00
Allurion Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s(Businesswire)
2024-05-29 04:05
Allurion to Participate in Two Upcoming Investor Conferences in June 2024(Businesswire)

Page 1 of 3

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.